|
|
|
|
Clinical Trials Update: June 25, 2009
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch: Irritable Bowel Syndrome (IBS) If you have irritable bowel syndrome, you may qualify for this study.The research site is in Bristol, Tenn. Diabetes ...
National Womens Health Information Center:
Jun 25 2009 6:29PM
Matching: insulin diabetes mellitus
|
Find similar documents
|
|
|
|
Insulin advice
AS the summer holidays approach, the Insulin Dependent Diabetes Trust (IDDT) knows that going away, especially abroad, is not straightforward for people with diabetes.The added security now present in airports and on...
|
|
|
Diabetes, insulin and holidays
THE summer holidays are approaching and your readers are preparing to go on holiday.The Insulin Dependent Diabetes Trust (IDDT) know that going on holiday, especially abroad, is not straight forward for people with...
|
|
|
New Study Highlights Rising Number of Type 2 Diabetes Patients in U.S., Increasing Complexity of Treatments
Contacts: Phil Oliva External Affairs Communications Gary Gatyas Communications (610) 834-5338 Health Services Research Network Academics Use IMSs Extensive Information Assets to Assess Trends in Managing a Disease Affecting Millions NORWALK...
|
|
|
What Is The Relationship Between Hepatocellular Carcinoma And Type 2 Diabetes Mellitus?
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths.Type 2 diabetes mellitus has been associated with HCC. However, the relationship between type 2 diabetes...
|
|
|
InteKrin Therapeutics Announces INT131 Phase 2a Results At The 2009 American Diabetes Association Annual Meeti
InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131 provides anti-diabetic efficacy consistent...
|
|
|
VIAject Presentations at ADA Meeting Highlight Drug's Mechanism of Absorption and Microvascular Effects
Biodel Board Member Honored at ADA Awards Ceremony DANBURY, Conn.--(BUSINESS WIRE)--Jun 8, 2009 - Biodel, Inc.(Nasdaq:BIOD) today reported new information regarding the mechanism of action of VIAject (injectable prandial insulin)...
|
|
|
InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeti
LOS ALTOS, Calif., June 10 /PRNewswire/ -- InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131...
|
|
|
InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeti
LOS ALTOS, Calif., June 10 /PRNewswire/ -- InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131...
|
|
|
Clinical Trials Update: June 9, 2009
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com: Diabetes Mellitus, Type 2 If you are an adult with type 2 diabetes and are not taking insulin, you may qualify for...
National Womens Health Information Center:
Jun 9 2009 6:36PM
Matching: insulin diabetes mellitus
|
Find similar documents
|
|
|
|
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
MONTREAL, June 8 /CNW/ - ConjuChem Biotechnologies, Inc.(TSX:CJB), today announced that it presented two posters at the 69th Scientific Sessions of the 2009 American Diabetes Association meeting held in New Orleans, LA on June 5-9,...
|
|
|
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
MONTREAL, June 8 /CNW/ - ConjuChem Biotechnologies, Inc.(TSX:CJB), today announced that it presented two posters at the 69th Scientific Sessions of the 2009 American Diabetes Association meeting held in New Orleans, LA on June 5-9,...
|
|
|
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
MONTREAL, June 8 /CNW/ - ConjuChem Biotechnologies, Inc.(TSX:CJB - News), today announced that it presented two posters at the 69th Scientific Sessions of the 2009 American Diabetes Association meeting held in New Orleans, LA on...
|
|
|
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
MONTREAL, June 8 /CNW/ - ConjuChem Biotechnologies, Inc.(TSX:CJB - News), today announced that it presented two posters at the 69th Scientific Sessions of the 2009 American Diabetes Association meeting held in New Orleans, LA on...
|
|
|
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
(Canada NewsWire via COMTEX) -- CJBFF | Quote | Chart | News | PowerRating -- ConjuChem Biotechnologies, Inc.(TSX:CJB), today announced that it presented two posters at the 69th Scientific Sessions of the 2009 American Diabetes...
|
|
|
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
'The presentations highlight the unique and highly competitive aspects of our two diabetes products, and showcase the value of our proprietary approach to extending the therapeutic window of short-lived therapeutic peptides,' said Dr.
|
|
|
Insulin Dependent Diabetes Trust is there to help
THERE are a growing number of children in the UK developing Type 1 diabetes and no doubt some of these children will be in your area.The Insulin Dependent Diabetes Trust offers support and a listening ear to the...
|
|
|
Effect of Fenofibrate on Amputation Events in People With Type 2 Diabetes Mellitus (FIELD Study): A Prespecifi
Fenofibrate treatment may lower the risk of amputations for patients with type 2 diabetes, particularly minor amputations without a known large-vessel disease, new research suggests.The Fenofibrate Intervention and Event Lowering in ...
|
|
|
Diasome Pharmaceuticals to Present at 2009 ADA Scientific Sessions
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Diasome Pharmaceuticals, a clinical stage diabetes therapeutics company, today announced that its abstract was selected for presentation at the 69th Diasome Pharmaceuticals poster presentation will be...
|
|
|
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Repaglinide Teva
International Nonproprietary Name (INN): repaglinide LONDON, April 23, 2009-On 23 April 2009 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion,** recommending to grant a marketing authorisation for the...
|
